ArticleFrontiers in immunology2022

Case Report: Maintenance Nivolumab in Complete Responder After Multimodality Therapy in Metastatic Pancreatic Adenocarcinoma.

Shih-Hung Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.